In this conversation, Bioaccess® CEO Julio Martinez-Clark shares how his team helps medtech, biopharma, and radiopharmaceutical innovators run faster, smarter first-in-human and early clinical trials by going global—especially in Latin America, Eastern Europe, and Australia. Julio explains the origin story of Bioaccess at the University of Miami, lessons from his pivot out of telecom after the dot-com bust, and why “rolling the dice” is part of building a category-defining CRO. He also opens up about leadership rooted in impact, the power of an entrepreneurial team, and a bold new radiopharmaceuticals and theranostics program being built in Colombia to speed access for patients across the region.
What you’ll learn


Why many startups take first-in-human trials overseas—and how to pick the right sites


Real talk on risk: hiring, site selection, and navigating regulatory delays


A playbook for impact-first leadership and building an entrepreneurial team


How radiopharmaceuticals/theranostics could change patient care in Latin America


Julio’s personal habits for learning fast and leading well


 
---------------------------------------------------------- Be a Guest: Are you a successful Naples-area business owner, entrepreneur, or professional with insights to share? Apply to be a guest at Driven: Unscripted Success and share your expertise with a wide audience eager to learn about you.

Ver todos los episodios